Faeth Therapeutics Statistics
NASDAQ: FTHHealthcareBiotechnologyUSD
24.92-1.97 (-7.33%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Faeth Therapeutics by the numbers
Faeth Therapeutics has a market capitalization of $643.9 million based on 25.84M shares outstanding. With trailing EPS of $-56.49, Faeth Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.6% below its 50-day average and 3.0% above its 200-day average.
Average daily trading volume is 352.35K shares, or about $8.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FTH valuation vs. peer median
| Metric | FTH | Peer median | Difference |
|---|---|---|---|
| Market cap | $643.94M | $657.76M | -2% |
| Avg. volume | 352.35K | 1.28M | -72% |
Peer median across 8 companies: ABUS, ZVRA, SGMT, PROK, NVCT, OABI, AURA, CLYM.
Valuation
- Market cap
- $643.94M
- EPS (TTM)
- $-56.49
- Shares outstanding
- 25.84M
Price and trading
- Previous close
- 26.89
- Open
- 26.71
- Day range
- 23.95 – 27.03
- 52-week range
- 7.45 – 42.14
- 52-week change
- +121.39%
- Beta
- —
- Volume
- 322.58K
- Average volume
- 352.35K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 643.94M
- Forward Pe
- -5.55
- Eps
- -56.49
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 42.14
- Week52 Low
- 7.45
- Avg Volume
- 352.35K
- Shares Outstanding
- 25.84M
- Ma50
- 31.78
- Ma200
- 24.20
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -40.87%
- Pct From52w Low
- 234.50%